© 2019 Future Science Group

Unitec House, 2 Albert Place,

London, N3 1QB, UK

Email: info@future-science-group.com
Tel: +44 (0)20 8371 6090

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle

News

July 11, 2017

Future Medicine and Future Science announce new website launches

The new and completely redesigned websites put the article first.

 

Future Science Group have launched redesigns of their websites FutureMedicine.com and Future-Science.com. Working closely with Atypon, the sites have been designed to provide quick and easy access to clear, well-structured and uncluttered article pages across all platforms and devices.

 

The website was developed with the user experience in mind; the sites include many new features to help users to quickly and easily navigate the site to see the full journal and eBook portfolio, as well as new social capabilities, offering users a 1-click ability to share articles across their social networks.

 

“We’re proud of the new websites and are delighted with the clean, no-fuss format,” said Phillip Garner, Managing Director. “The sites have been developed in a way to make the article the main focus, removing or hiding menus and folders wherever possible, and have de-cluttered, to provide the reader with a clean article view.”

 

For existing users, we have bolted on this new front-end design to the existing back-end, so there is no need to create new accounts or profiles – making this a seamless transition.

 

To view the sites, please visit https://www.futuremedicine.com/ and https://www.future-science.com/

 

 

–ENDS–

 

 

About Future Science Group

 

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG’s portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

 

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.